Engineered antibody fragments for immuno-PET imaging of endogenous CD8+ T cells in vivo. - Wikidata - wikimedia - TriplyDB

Engineered antibody fragments for immuno-PET imaging of endogenous CD8+ T cells in vivo.

Engineered antibody fragments for immuno-PET imaging of endogenous CD8+ T cells in vivo.

http://www.wikidata.org/entity/Q37519517

about

Utilizing population variation, vaccination, and systems biology to study human immunology High-content molecular profiling of T-cell therapy in oncology Imaging Biomarkers in Immunotherapy Nuclear Molecular Imaging Strategies in Immune Checkpoint Inhibitor Therapy.64Cu antibody-targeting of the T-cell receptor and subsequent internalization enables in vivo tracking of lymphocytes by PET.ImmunoPET/MR imaging allows specific detection of Aspergillus fumigatus lung infection in vivo Noninvasive imaging of immune responses.An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy.Molecular imaging of bacterial infections in vivo: the discrimination of infection from inflammation.Immuno-PET of Murine T Cell Reconstitution Postadoptive Stem Cell Transplantation Using Anti-CD4 and Anti-CD8 Cys-Diabodies.Imaging of Brown Adipose Tissue: State of the Art In vivo imaging with antibodies and engineered fragments.ImmunoPET Imaging of Murine CD4+ T Cells Using Anti-CD4 Cys-Diabody: Effects of Protein Dose on T Cell Function and Imaging.Molecular imaging in ovarian cancer.Advances in PET Detection of the Antitumor T Cell Response.Checkpoint Inhibitors in Head and Neck Cancer: Rationale, Clinical Activity, and Potential Biomarkers.Advancing Immune and Cell-Based Therapies Through Imaging.Noninvasive Imaging of Human Immune Responses in a Human Xenograft Model of Graft-Versus-Host Disease.In-depth Characterization of a TCR-specific Tracer for Sensitive Detection of Tumor-directed Transgenic T Cells by Immuno-PET Enzyme-Mediated Modification of Single-Domain Antibodies for Imaging Modalities with Different Characteristics.A PET Imaging Strategy to Visualize Activated T Cells in Acute Graft-versus-Host Disease Elicited by Allogenic Hematopoietic Cell Transplant.Murine Lymphocyte Labeling by 64Cu-Antibody Receptor Targeting for In Vivo Cell Trafficking by PET/CT.Imaging the Tumor Microenvironment.Imaging the multiple facets of immuno-oncology.Immuno-PET imaging of tumor-infiltrating lymphocytes using zirconium-89 radiolabeled anti-CD3 antibody in immune-competent mice bearing syngeneic tumors.Emerging biomarkers for PD-1 pathway cancer therapy.Aligning physics and physiology: Engineering antibodies for radionuclide delivery.Fluorine-19 MRI for detection and quantification of immune cell therapy for cancer Role of noninvasive molecular imaging in determining response

P2860

Q26799374-7DB282A7-CAE4-4B32-AB26-FC1DA93F22E1 Q28066792-D07003E5-D658-4E60-8867-EBEAC1552EBA Q28079871-2D8A3A23-59AE-4946-8284-1DF1AF8A4DDD Q33850467-15692D97-B735-4015-BD31-5E82025D7F65 Q34458153-C4866EBD-82CD-4A23-A528-A0E4E46BBE7F Q34509927-13C3AB89-7FF1-427D-8F83-9E633EDE6517 Q35616275-6447E915-DB87-47B4-B1FC-8988423A6F23 Q36437102-431FC55E-E173-4CAF-AC3B-FA9C2706BCF7 Q36683890-258BACD3-0077-426C-B237-B0212C233CBD Q36877472-E19AD2E8-740F-4727-A97D-F961BE4DB9A8 Q37090066-16A380B4-5282-47FE-9BC5-1BE1061F4259 Q38454458-35EDA271-CECB-4D87-B76B-A57330591EB7 Q38783061-A7235C2A-B9BD-4203-9FE4-7A1B43E686CC Q38824319-55D7F0F5-48E3-45A0-909E-7FA6FE00BB75 Q38846891-F04A8579-C1D0-434E-8B9D-9803906F06AC Q38868396-7F7DA7EE-5D61-4A55-BDA2-791DACACA2AF Q39167485-DEA882EC-E606-4A53-A7D0-83AE94CCD2B6 Q40328875-B9FAAB07-2FF5-4422-8AF6-1A12980AC643 Q41114267-20F925F0-9BE9-4CE0-9708-4362E2639129 Q43080054-A891FC3B-FBAF-4874-A17E-B353BEC15BE7 Q46121892-7C876040-3B80-4FE9-93AF-A494AC655D68 Q48554795-A9249B06-AD29-40BE-AD47-AB33E6091220 Q49592815-3487A969-826F-4392-B7F8-B3EFC2D057F5 Q50101315-5D71FA92-7457-42C3-942C-19F2F63D611A Q50532150-F24ED74F-65E9-4592-BBA8-8ED5FBEA9793 Q51275962-A79080BE-8F20-4154-9326-A260D8683C4A Q51740406-E8AC40AB-C3FA-4642-AF33-B106004CC75D Q57280956-FBF875B5-26DF-4BCE-B255-A5E8EE7A3305 Q58119177-CC73FB67-81B0-4384-9D48-2604A2257FD8

P2860

Engineered antibody fragments for immuno-PET imaging of endogenous CD8+ T cells in vivo.

http://www.wikidata.org/entity/Q37519517

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Engineered antibody fragments for immuno-PET imaging of endogenous CD8+ T cells in vivo.

@en

Engineered antibody fragments for immuno-PET imaging of endogenous CD8+ T cells in vivo.

@nl

type

label

Engineered antibody fragments for immuno-PET imaging of endogenous CD8+ T cells in vivo.

@en

Engineered antibody fragments for immuno-PET imaging of endogenous CD8+ T cells in vivo.

@nl

prefLabel

Engineered antibody fragments for immuno-PET imaging of endogenous CD8+ T cells in vivo.

@en

Engineered antibody fragments for immuno-PET imaging of endogenous CD8+ T cells in vivo.

@nl

P1433

Q37519517-21954D80-C384-432B-AB0E-46065FB61303

P1476

Q37519517-5D788FE4-B675-48C2-941B-099A1F72C311

P2093

Q37519517-1104C5DE-CAE0-46FB-AAB6-D472607B58DE

Q37519517-405989E9-26F9-4787-9711-884D63FABFA5

Q37519517-66898029-7523-4CF9-AD42-EA4E913B60BB

Q37519517-88969D5B-A89A-4BB2-854F-A9C3474604B5

Q37519517-C3C6B986-D08A-4355-ABBA-F269D7A38989

Q37519517-EBB5A33D-E73F-4DA1-A187-6AD45D7F0A89

Q37519517-EED1B45B-0E28-4ED7-A5A6-2103B79F2DF2

P2860

Q37519517-004E351B-1472-4059-9960-2300DE5F679A

Q37519517-37197C65-DFF8-4716-AD49-9273107CD85A

Q37519517-3C6C51F7-CDEB-4F4D-AAFB-3991D1CB56DF

Q37519517-3D44264F-5B33-43A4-B2F6-EB1FDFD0933D

Q37519517-44045D15-7AAF-4687-B5F2-FE945D6416F6

Q37519517-44BD4D97-1C93-490F-B5EF-EB3363DF7535

Q37519517-4E2932B1-DA86-4BC6-A7FB-42F4CB2555A7

Q37519517-50D294A5-B464-4B56-9B2B-4F7C873D918C

Q37519517-6E9BFED2-7390-4B46-9054-AE2A34615065

Q37519517-8476770F-3F9F-4001-B401-1216F20237E5

P304

Q37519517-B914F6C9-2BCB-4554-B375-731F8B446B7C

P31

Q37519517-69AF97E3-E951-4322-A59D-C9879ABCE371

P356

Q37519517-87D0857E-A7A3-42CC-8E26-07AE93496221

P407

Q37519517-E2200250-CA54-4C5D-A957-F7D01E79B830

P433

Q37519517-02AE8F0F-F803-49C3-B5F3-68F882706066

P478

Q37519517-D63E7E97-AC2B-45C1-B0FA-C6F9C4FFA65D

P50

Q37519517-5A001A0B-20D1-45B4-A3AA-0EC383322590

P577

Q37519517-1B046771-B519-45CE-B823-583E04FA2813

P5875

Q37519517-C6B0F1CB-33C9-48BC-B403-B7F4127A1106

P698

Q37519517-DC9D8525-A896-4129-890E-9E05928440F0

P921

Q37519517-0C65F615-1A96-4481-AF56-DF9CE2BE989C

P932

Q37519517-6F66C56E-8C70-4F60-A083-1E4270826D57

P356

PNAS.1316922111

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Engineered antibody fragments for immuno-PET imaging of endogenous CD8+ T cells in vivo.

@en

P2093

Felix B Salazar

http://www.w3.org/2001/XMLSchema#string

Kirstin A Zettlitz

http://www.w3.org/2001/XMLSchema#string

Melissa N McCracken

http://www.w3.org/2001/XMLSchema#string

Owen N Witte

http://www.w3.org/2001/XMLSchema#string

Richard Tavaré

http://www.w3.org/2001/XMLSchema#string

Scott M Knowles

http://www.w3.org/2001/XMLSchema#string

Tove Olafsen

http://www.w3.org/2001/XMLSchema#string

P2860

In vivo imaging of T cell delivery to tumors after adoptive transfer therapy.

Kinetic phases of distribution and tumor targeting by T cell receptor engineered lymphocytes inducing robust antitumor responses.

Development of a novel long-lived immunoPET tracer for monitoring lymphoma therapy in a humanized transgenic mouse model.

Stability engineering of antibody single-chain Fv fragments.

ImmunoPET imaging of B-cell lymphoma using 124I-anti-CD20 scFv dimers (diabodies).

Recombinant anti-CD20 antibody fragments for small-animal PET imaging of B-cell lymphomas.

PET probes for distinct metabolic pathways have different cell specificities during immune responses in mice

Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imaging.

Arming antibodies: prospects and challenges for immunoconjugates.

Differential uptake of (18)F-fluorodeoxyglucose by experimental tumors xenografted into immunocompetent and immunodeficient mice and the effect of immunomodification.

P304

1108-1113

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1316922111

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-01-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259588159

http://www.w3.org/2001/XMLSchema#string

P698

24390540

http://www.w3.org/2001/XMLSchema#string

P921

P932

3903195

http://www.w3.org/2001/XMLSchema#string